Medicinal properties of adamantane derivatives.
D000970:Antineoplastic Agents; D000978:Antiparkinson Agents; D000998:Antiviral Agents; D001952:Bridged-Ring Compounds / Q000627:therapeutic use*; D003516:Cycloparaffins / Q000627:therapeutic use; D004794:Enzyme Repression; D006801:Humans; D006993:Hypnotics and Sedatives; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D000978:Antiparkinson Agents; D000998:Antiviral Agents; D001952:Bridged-Ring Compounds; D003516:Cycloparaffins; D006993:Hypnotics and Sedatives